Mirion Technologies, Inc (NYSE:MIR) Accelerates Nuclear Contracts While Valuation Signals Pressure

Robust contract activity and a cash-rich balance sheet support Mirion’s market positioning, yet stretched valuation and weakening momentum suggest near-term price pressure ahead.

Recent News

On March 4, 2026 Mirion named an official partner for World Engineering Day for Sustainable Development. On February 10, 2026 Mirion, Paragon and Certrec showcased unified nuclear solutions at the US NIC Advanced Reactors Summit. Between February 11–13, 2026 Mirion launched a webinar series to support advanced nuclear projects and presented at Citi’s Global Industrial Tech & Mobility Conference, highlighting nuclear market opportunities and AI initiatives.

Technical Analysis

Directional Indicators (ADX / DI+ / DI-): ADX at 40.83 signals a very strong trend environment. DI+ peaked-and-reversed at 10.82, which signals a bearish directional shift; DI- peaked-and-reversed at 29.55, which signals a bullish directional shift. Those opposing DI signals, combined with a high ADX, imply a decisive trend that lacks clear directional agreement—heightened volatility likely until one side asserts control; this complicates immediate recovery given the stated over-valued status.

MACD: MACD stands at -0.96 with a peak-and-reversal trend and the MACD line below the signal (-0.93), producing a bearish momentum profile that reinforces near-term downward bias against valuation pressure.

MRO (Momentum/Regression Oscillator): MRO at -11.76 (decreasing) indicates the market price sits below the target and carries potential to push higher; the decreasing MRO reduces that potential, suggesting any corrective lift may remain limited relative to valuation headwinds.

RSI: RSI at 41.64 and decreasing indicates waning upside momentum without an oversold reading, lowering the probability of a strong immediate rebound and aligning with the technical bearish tilt.

Price Versus Moving Averages and Bands: Last close $18.81 trades below the 12-day EMA ($19.57, decreasing), 20-day average ($19.75), 50-day average ($22.58) and 200-day average ($22.95), reinforcing near-term downside bias. Price sits near the 1x lower Bollinger band ($18.52), which could cap immediate downside but does not negate the prevailing bearish momentum.

 


Fundamental Analysis

Profitability: EBIT of $10,100,000 yields an EBIT margin of 4.53%. Year-over-year the EBIT margin rose by 750.94% while quarter-over-quarter the margin contracted by 48.52%. The company’s EBIT margin sits below the industry peer mean of 15.13% and below the industry peer median of 19.51%, indicating lower operating profitability relative to peers.

Revenue and Earnings: Total revenue $223,100,000. Revenue growth year-over-year registered at -162.07% and quarter-over-quarter at -99.13%, while the generic revenue growth figure shows 0.09%; the YoY and QoQ figures indicate material short-term variability in top-line trends. Reported EPS came in at $0.15 versus an estimate of $0.16, an EPS surprise of -6.25%.

Cash, Liquidity and Cash Generation: Cash and short-term investments total $939.7M with a cash ratio of 3.27x and a current ratio of 4.83x, signaling strong near-term liquidity. Operating cash flow measured $22.3M and free cash flow $13.0M, producing a free cash flow yield of 0.23% and a free cash to net income ratio of 4.48x. Cash conversion cycle stands at 134.07 days, modestly above the industry peer mean of 131.54 days but still within the industry peer range.

Capital Structure and Coverage: Total debt $1,232,800,000 yields net debt of $265,200,000. Debt-to-EBITDA reads 27.40x and interest coverage stands at 1.13x, constraining financial flexibility despite ample cash on hand. Debt-to-equity sits at 0.67x.

Valuation Metrics: Trailing P/E registers at 2,264.51 while forward P/E measures 136.44; price-to-sales equals 25.42 and price-to-book equals 3.08. Enterprise multiple reads 132.54. The current valuation as determined by WMDST: over-valued. These elevated multiples, paired with low free cash flow yield and thin interest coverage, underline valuation risk absent improved margin conversion and cash generation.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-09-30
REPORT DATE: 2026-02-10
NEXT REPORT DATE: 2026-05-12
CASH FLOW  Begin Period Cash Flow 263.0 M
 Operating Cash Flow 22.3 M
 Capital Expenditures -9.30 M
 Change In Working Capital -20.10 M
 Dividends Paid
 Cash Flow Delta 670.6 M
 End Period Cash Flow 933.6 M
 
INCOME STATEMENT REVENUE
 Total Revenue 223.1 M
 Forward Revenue 856.0 M
COSTS
 Cost Of Revenue 118.6 M
 Depreciation 34.9 M
 Depreciation and Amortization 34.9 M
 Research and Development 10.1 M
 Total Operating Expenses 215.7 M
PROFITABILITY
 Gross Profit 104.5 M
 EBITDA 45.0 M
 EBIT 10.1 M
 Operating Income 7.4 M
 Interest Income 2.2 M
 Interest Expense 8.9 M
 Net Interest Income -6.70 M
 Income Before Tax 1.2 M
 Tax Provision -1.90 M
 Tax Rate 21.0 %
 Net Income 2.9 M
 Net Income From Continuing Operations 3.1 M
EARNINGS
 EPS Estimate 0.16
 EPS Actual 0.15
 EPS Difference -0.01
 EPS Surprise -6.25 %
 Forward EPS 0.18
 
BALANCE SHEET ASSETS
 Total Assets 3.5 B
 Intangible Assets 1.9 B
 Net Tangible Assets -65.80 M
 Total Current Assets 1.4 B
 Cash and Short-Term Investments 939.7 M
 Cash 933.2 M
 Net Receivables 150.0 M
 Inventory 146.0 M
 Long-Term Investments 16.8 M
LIABILITIES
 Accounts Payable 49.4 M
 Short-Term Debt 1.6 M
 Total Current Liabilities 287.0 M
 Net Debt 265.2 M
 Total Debt 1.2 B
 Total Liabilities 1.6 B
EQUITY
 Total Equity 1.8 B
 Retained Earnings -530.00 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 7.35
 Shares Outstanding 250.750 M
 Revenue Per-Share 0.89
VALUATION
 Market Capitalization 5.7 B
 Enterprise Value 6.0 B
 Enterprise Multiple 132.544
Enterprise Multiple QoQ 35.978 %
Enterprise Multiple YoY 101.738 %
Enterprise Multiple IPRWA high: 185.353
MIR: 132.544
median: 76.114
mean: 72.692
low: -109.976
 EV/R 26.734
CAPITAL STRUCTURE
 Asset To Equity 1.899
 Asset To Liability 2.18
 Debt To Capital 0.401
 Debt To Assets 0.353
Debt To Assets QoQ 11.605 %
Debt To Assets YoY 153226.087 %
Debt To Assets IPRWA high: 1.311
MIR: 0.353
mean: 0.243
median: 0.153
low: 0.002
 Debt To Equity 0.67
Debt To Equity QoQ 13.173 %
Debt To Equity YoY 167282.5 %
Debt To Equity IPRWA high: 2.204
MIR: 0.67
mean: 0.408
median: 0.223
low: -1.277
PRICE-BASED VALUATION
 Price To Book (P/B) 3.08
Price To Book QoQ -2.272 %
Price To Book YoY 70.318 %
Price To Book IPRWA high: 15.33
median: 4.517
mean: 3.914
MIR: 3.08
low: -8.81
 Price To Earnings (P/E) 2264.512
Price To Earnings QoQ 244.539 %
Price To Earnings YoY 1431.821 %
Price To Earnings IPRWA MIR: 2264.512
high: 259.394
median: 101.806
mean: 95.026
low: -207.228
 PE/G Ratio -33.968
 Price To Sales (P/S) 25.421
Price To Sales QoQ 22.946 %
Price To Sales YoY 91.385 %
Price To Sales IPRWA high: 176.909
MIR: 25.421
mean: 22.217
median: 20.242
low: 0.307
FORWARD MULTIPLES
Forward P/E 136.437
Forward PE/G -2.047
Forward P/S 7.479
EFFICIENCY OPERATIONAL
 Operating Leverage -540.191
ASSET & SALES
 Asset Turnover Ratio 0.072
Asset Turnover Ratio QoQ -13.884 %
Asset Turnover Ratio YoY -8.606 %
Asset Turnover Ratio IPRWA high: 0.52
mean: 0.166
median: 0.135
MIR: 0.072
low: 0.0
 Receivables Turnover 1.527
Receivables Turnover Ratio QoQ -0.664 %
Receivables Turnover Ratio YoY 7.697 %
Receivables Turnover Ratio IPRWA high: 3.929
MIR: 1.527
mean: 1.485
median: 1.39
low: 0.148
 Inventory Turnover 0.815
Inventory Turnover Ratio QoQ -2.341 %
Inventory Turnover Ratio YoY 8.132 %
Inventory Turnover Ratio IPRWA high: 2.783
MIR: 0.815
mean: 0.765
median: 0.737
low: 0.001
 Days Sales Outstanding (DSO) 59.756
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 134.067
Cash Conversion Cycle Days QoQ -5.438 %
Cash Conversion Cycle Days YoY -8.355 %
Cash Conversion Cycle Days IPRWA high: 605.436
MIR: 134.067
mean: 131.535
median: 113.839
low: -371.003
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.203
 CapEx To Revenue -0.042
 CapEx To Depreciation -0.266
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.0 B
 Net Invested Capital 3.0 B
 Invested Capital 3.0 B
 Net Tangible Assets -65.80 M
 Net Working Capital 1.1 B
LIQUIDITY
 Cash Ratio 3.274
 Current Ratio 4.831
Current Ratio QoQ 89.853 %
Current Ratio YoY 123.312 %
Current Ratio IPRWA high: 13.125
MIR: 4.831
mean: 2.112
median: 1.703
low: 0.117
 Quick Ratio 4.323
Quick Ratio QoQ 114.832 %
Quick Ratio YoY 178.191 %
Quick Ratio IPRWA high: 7.703
MIR: 4.323
mean: 1.571
median: 1.243
low: 0.377
COVERAGE & LEVERAGE
 Debt To EBITDA 27.396
 Cost Of Debt 0.67 %
 Interest Coverage Ratio 1.135
Interest Coverage Ratio QoQ -31.679 %
Interest Coverage Ratio YoY 1354.724 %
Interest Coverage Ratio IPRWA high: 340.0
mean: 26.672
median: 19.017
MIR: 1.135
low: -401.025
 Operating Cash Flow Ratio 0.115
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 36.0
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 27.686 %
 Revenue Growth 0.09 %
Revenue Growth QoQ -99.13 %
Revenue Growth YoY -162.069 %
Revenue Growth IPRWA high: 54.24 %
median: 2.034 %
mean: 2.004 %
MIR: 0.09 %
low: -45.858 %
 Earnings Growth -66.667 %
Earnings Growth QoQ -4.761 %
Earnings Growth YoY 233.335 %
Earnings Growth IPRWA high: 180.0 %
mean: 10.402 %
median: 3.175 %
MIR: -66.667 %
low: -100.918 %
MARGINS
 Gross Margin 46.84 %
Gross Margin QoQ 1.859 %
Gross Margin YoY 4.267 %
Gross Margin IPRWA high: 94.309 %
mean: 56.367 %
median: 55.361 %
MIR: 46.84 %
low: -37.943 %
 EBIT Margin 4.527 %
EBIT Margin QoQ -48.516 %
EBIT Margin YoY 750.94 %
EBIT Margin IPRWA high: 38.373 %
median: 19.512 %
mean: 15.128 %
MIR: 4.527 %
low: -908.773 %
 Return On Sales (ROS) 3.317 %
Return On Sales QoQ -25.31 %
Return On Sales YoY 523.496 %
Return On Sales IPRWA high: 34.618 %
median: 17.673 %
mean: 14.189 %
MIR: 3.317 %
low: -971.016 %
CASH FLOW
 Free Cash Flow (FCF) 13.0 M
 Free Cash Flow Yield 0.229 %
Free Cash Flow Yield QoQ 193.59 %
Free Cash Flow Yield YoY 61.268 %
Free Cash Flow Yield IPRWA high: 9.514 %
median: 0.995 %
mean: 0.812 %
MIR: 0.229 %
low: -42.542 %
 Free Cash Growth 261.111 %
Free Cash Growth QoQ -401.111 %
Free Cash Growth YoY -5452.829 %
Free Cash Growth IPRWA MIR: 261.111 %
high: 195.075 %
median: 43.065 %
mean: 17.324 %
low: -266.667 %
 Free Cash To Net Income 4.483
 Cash Flow Margin 14.747 %
 Cash Flow To Earnings 11.345
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 0.093 %
Return On Assets QoQ -70.0 %
Return On Assets YoY -118.058 %
Return On Assets IPRWA high: 8.176 %
mean: 1.849 %
median: 1.844 %
MIR: 0.093 %
low: -70.984 %
 Return On Capital Employed (ROCE) 0.315 %
 Return On Equity (ROE) 0.002
Return On Equity QoQ -72.359 %
Return On Equity YoY -117.542 %
Return On Equity IPRWA high: 0.969
median: 0.029
MIR: 0.002
mean: -0.001
low: -1.516
 DuPont ROE 0.176 %
 Return On Invested Capital (ROIC) 0.262 %
Return On Invested Capital QoQ -61.185 %
Return On Invested Capital YoY -141.786 %
Return On Invested Capital IPRWA high: 18.508 %
mean: 3.204 %
median: 2.609 %
MIR: 0.262 %
low: -26.281 %

Six-Week Outlook

Near-term momentum favors a cautionary stance. Technical momentum indicators (MACD negative, RSI falling, price beneath major moving averages) point toward continued pressure on the stock. Contrasting signals—MRO negative (price below target) and price near the lower Bollinger band—suggest limited upside potential for corrective rebounds, but any bounce may lack conviction while valuation remains over-valued. Liquidity and cash reserves provide fundamental support; however, weak coverage metrics and elevated leverage ratios limit catalyst weight from fundamentals alone. Expect choppy price action with volatility likely to favor downside probes unless management delivers clearer margin expansion or materially stronger cash generation in upcoming reports.

About Mirion Technologies, Inc.

Mirion Technologies, Inc. (NYSE:MIR) develops and delivers advanced radiation detection, measurement, analysis, and monitoring solutions across a global market. With operations spanning the United States, Canada, Europe, and Asia, Mirion caters to a diverse clientele including medical facilities, industrial companies, government agencies, and military organizations. The company organizes its offerings into two primary segments: Medical and Technologies. The Medical segment provides comprehensive solutions for radiation oncology quality assurance, dosimetry, and patient safety in diagnostic imaging and radiation therapy centers. It also offers products for radionuclide therapy, supporting applications in medical diagnostics, cancer treatment, and practitioner safety. The Technologies segment addresses critical radiation safety and measurement needs, supplying personal radiation detection and identification equipment, as well as analysis tools. Mirion’s extensive product portfolio includes nuclear medicines, dosimeters, contamination monitors, reactor instrumentation, and control systems. Additionally, the company offers medical and industrial imaging systems, alpha and gamma spectroscopy instruments, and various software solutions. Founded in 2005 and headquartered in Atlanta, Georgia, Mirion Technologies continues to serve a broad spectrum of industries, ensuring safety and precision in environments where radiation plays a critical role.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.